NPTX1 and central nervous system cancer: In glioma, the level of miR-128-3p expression was dramatically attenuated in glioma clinical tissues, and miR-128-3p regulated the progression of glioma via targeting NPTX1 and activating the IRS-1/PI3K/AKT signaling pathway [12].